216 filings
8-K
PDSB
PDS Biotechnology Corporation
2 May 24
PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
6:01am
8-K
PDSB
PDS Biotechnology Corporation
27 Mar 24
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
7:30am
8-K
PDSB
PDS Biotechnology Corporation
13 Mar 24
Patent for composition of matter and use of Infectimune® based influenza vaccines granted in the United States
6:02am
8-K
PDSB
PDS Biotechnology Corporation
22 Jan 24
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer
5:10pm
8-K
PDSB
PDS Biotechnology Corporation
4 Dec 23
Other Events
4:02pm
8-K
wy0yyirv2c3zq
28 Nov 23
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
6:02am
8-K
nhlreic
14 Nov 23
PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update
12:00am
8-K
ggmi o0vktqbgl2
9 Nov 23
Other Events
4:07pm
8-K
eg2zckyejr5k ky2vi
23 Oct 23
PDS Biotech Announces Preliminary Biomarker Study Results in Subset of Advanced HPV-Positive Head and Neck Cancer Patients at ESMO
4:06pm
8-K
djzgp0 i7lnw
11 Oct 23
Other Events
4:02pm
8-K
04ya skjzgf0t1od6sz
3 Oct 23
Other Events
4:03pm
8-K
zj9jmmccl2p36xb4e ng
3 Oct 23
Other Events
4:03pm
8-K
s0d7kez5vcg
3 Oct 23
Other Events
9:02am
8-K
jv3thul3
2 Oct 23
Other Events
4:05pm
8-K
8qynkw
20 Sep 23
PDS Biotech Announces PDS0202 Elicits Active Neutralization of Multiple Influenza Strains in Preclinical Studies
4:10pm
8-K
glc diz2t
11 Sep 23
Other Events
4:05pm
8-K
5jbz1jeem
8 Sep 23
PDS0202 Universal Influenza Preclinical Ferret Data to be Presented in Oral Lecture at 9th ESWI Conference
6:02am
8-K
bwsj8 b6n
18 Aug 23
Other Events
4:04pm
8-K
ukd7875c
17 Aug 23
Other Events
4:05pm
8-K
w8tni0z
14 Aug 23
PDS Biotech Announces Submission of Phase 3 Protocol to FDA to Initiate VERSATILE-003 Trial
4:06pm